In the late 1980s, North Dakota avoided a measles outbreak that swept the rest of the country. Today, the state has it's first outbreak in 39 years. So what changed?

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

The FDA’s new policy limits COVID-19 vaccine eligibility to older adults and high-risk groups, excluding millions from ...

South Dakota has not had a confirmed case of measles so far this year, but last July, it reported its first measles case in nine years.

The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

An industry group responds, "Other than clean water, arguably nothing has done more to improve public health than vaccines." ...

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

FDA Commissioner Marty Makary was met with a skeptical set of Senate appropriators Thursday when he testified on his agency’s ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.

Adar Poonawalla, CEO, Serum Institute of India, on life after Covid, vaccine pricing, and expansion into new frontiers.